Navigation Links
Chemo for Mesothelioma Offers Limited Survival Benefits
Date:5/15/2008

Therapy does not appear to help quality of life for lung cancer linked to asbestos,,

THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not appear to improve either survival or quality of life.

Malignant pleural mesothelioma (MPM), which is usually fatal, is a cancer of the protective lining that covers the lungs. Asbestos is still produced or used in large quantities in countries such as Russia, China, Canada, Kazakhstan, Brazil, Zimbabwe, India and Thailand.

In the study, published in this week's issue of The Lancet, groups of mesothelioma patients received one of two chemotherapy regimes (four cycles of mitomycin, vinblastine and cisplatin every three weeks or one injection of vinorelbine every week for 12 weeks) in addition to active symptom control (ACS) treatments. ACS can include steroids, painkillers, bronchodilators and palliative radiotherapy to control the cancer's symptoms. Another group only received the symptom control treatments.

At the time of the analysis, roughly 96 percent of patients in all three groups had died. Only a slight but statistically insignificant improvement in survival rates after one year was found when comparing the two chemotherapy groups combined to those receiving only treatment for symptoms (32 percent vs. 29 percent).

Patients in the chemotherapy group that received vinorelbine, though, did have a slightly better survival rate (37 percent) than the other two groups but, again, researchers said this was not statistically significant.

Quality-of-life scores (physical functioning, pain, shortness of breath, overall health status) were similar in the three groups.

"The addition of chemotherapy to ASC offers no significant benefits in terms of overall survival or quality of life. However, exploratory analyses suggested that vinorelbine merits further investigation," the authors concluded.

More information

The National Cancer Institute has more about mesothelioma.



-- Kevin McKeever



SOURCE: The Lancet, news release, May 15, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Targeted therapy plus chemotherapy may pack 1-2 punch against melanoma
2. Blacks not receiving chemotherapy for rectal cancer, despite seeing cancer specialists
3. Black Rectal Cancer Patients Less Likely to Get Chemo, Radiation
4. Chemotherapy causes delayed severe neural damage
5. Common Chemotherapy Drug Linked to Memory Problems
6. Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
7. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
8. High-Dose Chemo Fails Against Small Cell Lung Cancers
9. High-intensity chemotherapy does not improve survival in small cell lung cancer
10. Most Cancer Survivors Say Chemo Fears Unfounded
11. Fasting Before Chemo Protects Healthy Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... ... FlipBelt, the fitness brand that specializes in problem solving fitness accessories, has brought ... launch of their FlipBelt Crops. , The new fitness bottoms feature an integrated FlipBelt ... the gym, on the trail, or on-the-go. , “We always thought the FlipBelt could ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... communities in northern Alabama and Georgia, is embarking on an extended charity drive ... modern early detection methods. , US Breast Cancer statistics show that over ...
(Date:9/20/2017)... ... September 20, 2017 , ... Reflections Recovery ... now accredited by The Joint Commission for chemical dependency and behavioral health services. ... U.S. health care organizations that meet the commission’s rigorous standards. Accreditation by The ...
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete Coatings announced that ... rely on safety and cleanliness. This unique flooring system uses silver ion technology ... for centuries for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, silver ...
(Date:9/20/2017)... Calif. (PRWEB) , ... September 20, 2017 , ... ... year of providing a voice for people who have kidney disease. The theme ... writers to share their stories. Entrants needed to meet only one qualification— ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir ... Smart Spirometer, announced today a partnership with Novartis Pharma AG ... solidifies NuvoAir,s position as the leading mobile spirometry platform and ... patients. ... test ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology: